Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Tc-99m HMDP (Hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. synthesis and distribution in animals. [Rats, dogs]

Conference · · J. Nucl. Med.; (United States)
OSTI ID:6861338
Technetium-99m hydroxymethylene diphosphonate (Tc-99m HMDP) is a new diphosphonate skeletal imaging agent. Animal studies show that Tc-99m HMDP has a higher uptake on bone and a more rapid clearance from the blood than any of the three technetium-labeled bone imaging agents in current use: Tc-99m methylene diphosphonate (MDP), Tc-99m (1-hydroxyethylidene) diphosphonate (HEDP), and Tc-99m pyrophosphate (PPi). On the basis of these animal studies, Tc-99m HMDP is a highly promising candidate for skeletal imaging.
Research Organization:
Procter and Gamble Co., Cincinnati, OH
OSTI ID:
6861338
Conference Information:
Journal Name: J. Nucl. Med.; (United States) Journal Volume: 21:10
Country of Publication:
United States
Language:
English

Similar Records

Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model
Conference · Wed Oct 01 00:00:00 EDT 1980 · J. Nucl. Med.; (United States) · OSTI ID:6852381

A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication
Journal Article · Wed Dec 31 23:00:00 EST 1980 · J. Nucl. Med.; (United States) · OSTI ID:5607737

Comparison of skeletal uptakes of three diphosphonates by whole-body retention. [Technetium 99]
Journal Article · Thu Oct 01 00:00:00 EDT 1981 · J. Nucl. Med.; (United States) · OSTI ID:5806145